Next Article in Journal
Structure–Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy
Next Article in Special Issue
A Physiologically-Based Pharmacokinetic Simulation to Evaluate Approaches to Mitigate Efavirenz-Induced Decrease in Levonorgestrel Exposure with a Contraceptive Implant
Previous Article in Journal
Oromucosal Administration of Oxytocin: The Development of ‘Oxipops’
Previous Article in Special Issue
Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict CYP3A-Mediated Drug Interaction between Saxagliptin and Nicardipine: Bridging Rat-to-Human Extrapolation
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(3), 334; https://doi.org/10.3390/pharmaceutics16030334
Action Date Notes Link
article pdf uploaded. 27 February 2024 16:44 CET Version of Record https://www.mdpi.com/1999-4923/16/3/334/pdf-vor
article xml file uploaded 28 February 2024 04:58 CET Original file -
article xml uploaded. 28 February 2024 04:58 CET Update https://www.mdpi.com/1999-4923/16/3/334/xml
article pdf uploaded. 28 February 2024 04:58 CET Updated version of record https://www.mdpi.com/1999-4923/16/3/334/pdf
article html file updated 28 February 2024 05:00 CET Original file https://www.mdpi.com/1999-4923/16/3/334/html
Back to TopTop